NUVL - Nuvalent, Inc.
102.67
2.450 2.386%
Share volume: 583,511
Last Updated: 03-04-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.72%
PREVIOUS CLOSE
CHG
CHG%
$100.22
0.00
0.00%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-09-2024 | 08-08-2024 | 11-12-2024 | 02-27-2025 | 05-08-2025 | 10-30-2025 | 02-26-2026 | |
| Assets | ||||||||
| Total Assets | 708.466 M | 675.230 M | 1.189 B | 1.142 B | 1.106 B | 979.910 M | 1.413 B | |
| Current Assets | 699.494 M | 666.258 M | 1.180 B | 1.132 B | 1.087 B | 956.945 M | 1.392 B | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 593.322 M | 580.294 M | 799.065 M | 972.611 M | 952.390 M | 827.351 M | 1.110 B | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 98.515 M | 77.700 M | 369.244 M | 145.691 M | 120.835 M | 115.752 M | 261.745 M | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Assets | 8.972 M | 8.972 M | 9.183 M | 9.304 M | 19.253 M | 22.965 M | 20.279 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | ||||||||
| Total Liabilities and shareholders’ equity | 708.466 M | 675.230 M | 1.189 B | 1.142 B | 1.106 B | 979.910 M | 1.413 B | |
| Total liabilities | 33.427 M | 38.192 M | 67.732 M | 71.960 M | 94.749 M | 134.511 M | 164.366 M | |
| Total current liabilities | 33.427 M | 38.192 M | 51.132 M | 54.020 M | 75.034 M | 89.151 M | 91.171 M | |
| Accounts Payable | 13.396 M | 7.403 M | 15.934 M | 5.225 M | 26.165 M | 22.010 M | 30.158 M | |
| Other liabilities | 0.000 | 0.000 | 16.600 M | 17.940 M | 19.715 M | 45.360 M | 73.195 M | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 0.000 | 0.000 | 16.600 M | 17.940 M | 19.715 M | 45.360 M | 73.195 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 675.039 M | 637.038 M | 1.121 B | 1.070 B | 1.011 B | 845.399 M | 1.248 B | |
| Common stock | 1.007 B | 1.027 B | 1.592 B | 1.617 B | 1.642 B | 1.697 B | 2.218 B | |
| Retained earnings | -330.778 M | -387.944 M | -472.289 M | -547.052 M | -631.634 M | -853.724 M | -972.429 M |